Evaluation of HexM and its high-level mannose 6-phosphorylated form, PhosHexM, as treatments of models of GM2 gangliosidoses
Molecular Therapy Advances · 2026-12 · 34 (4) · 201882
DOI: 10.1016/j.omta.2026.201882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy Advances, 2026-12. Verfasst von Mehrafarin Ashiri und 11 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- CIHR
Zitieren
APA
Ashiri, M., Barker, E. N., Wang, W., Vegh, C., Hedman, A., Liu, S., Liu, L., Hemming, R., Anjos, E., Whitehead, S. N., Mark, B. L., & Triggs-Raine, B. (2026). Evaluation of HexM and its high-level mannose 6-phosphorylated form, PhosHexM, as treatments of models of GM2 gangliosidoses. Molecular Therapy Advances, 34(4), 201882. https://doi.org/10.1016/j.omta.2026.201882
Vancouver
Ashiri M, Barker EN, Wang W, Vegh C, Hedman A, Liu S, et al. Evaluation of HexM and its high-level mannose 6-phosphorylated form, PhosHexM, as treatments of models of GM2 gangliosidoses. Molecular Therapy Advances. 2026;34(4):201882. doi:10.1016/j.omta.2026.201882
BibTeX
@article{Ashiri2026,
author = {Ashiri, Mehrafarin and Barker, Emily N. and Wang, Wenxuan and Vegh, Caleb and Hedman, Andrew and Liu, Shou and Liu, Lin and Hemming, Richard and Anjos, Elaine and Whitehead, Shawn N. and Mark, Brian L. and Triggs-Raine, Barbara},
title = {Evaluation of HexM and its high-level mannose 6-phosphorylated form, PhosHexM, as treatments of models of GM2 gangliosidoses},
journal = {Molecular Therapy Advances},
year = {2026},
volume = {34},
number = {4},
pages = {201882},
doi = {10.1016/j.omta.2026.201882}
}
EUVIMED